Drug Shortage Report for INNOHEP
Report ID | 79586 |
Drug Identification Number | 02231478 |
Brand name | INNOHEP |
Common or Proper name | tinzaparin sodium |
Company Name | LEO PHARMA INC |
Market Status | MARKETED |
Active Ingredient(s) | TINZAPARIN SODIUM |
Strength(s) | 20000UNIT |
Dosage form(s) | SOLUTION |
Route of administration | SUBCUTANEOUS |
Packaging size | 10 x 0.5mL |
ATC code | B01AB |
ATC description | ANTITHROMBOTIC AGENTS |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | 2019-03-27 |
Actual start date | 2019-03-27 |
Estimated end date | 2019-05-15 |
Actual end date | 2019-04-25 |
Shortage status | Resolved |
Updated date | 2019-04-26 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 3389 STEELES AVENUE EAST, SUITE 110 TORONTO, ONTARIO CANADA M2H 3S8 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v7 | 2019-04-26 | English | Compare |
v6 | 2019-04-25 | French | Compare |
v5 | 2019-04-25 | English | Compare |
v4 | 2019-04-25 | English | Compare |
v3 | 2019-03-28 | English | Compare |
v2 | 2019-03-27 | French | Compare |
v1 | 2019-03-27 | English | Compare |
Showing 1 to 7 of 7